Status:
UNKNOWN
Online Videodensitometric Assessment of Aortic Regurgitation in the Cath-Lab
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Amsterdam University Medical Center
Conditions:
Aortic Valve Insufficiency
Heart Valve Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Following the high feasibility of analyses by core laboratory with videodensitometry determined in the ASSESS-REGURGE Registry, this is an early clinical feasibility study of online videodensitometric...
Detailed Description
OVAL (Online Videodensitometric Assessment of Aortic Regurgitation in the Cath-Lab) is a single centre, prospective, proof-of-principle, feasibility study performed in the Academic Medical Centre (Ams...
Eligibility Criteria
Inclusion
- Consecutive patients with indication to undergo TAVR by the Institution's Heart Team.
Exclusion
- Patients that were not considered by the Institution's heart team as eligible
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04047082
Start Date
May 15 2019
End Date
September 1 2019
Last Update
August 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam University Medical Center
Amsterdam, Netherlands, 1105 AZ